BioTarget 2019 Final - Pitch Event

Cancer is a disease that affects far too many people, with one in two being diagnosed with cancer during their lifetime.

Scientific research has already changed the lives of many suffering from this disease, but there continues to be an urgent need for new breakthroughs in cancer drug development.

BioTarget directly addresses the urgent need for new drugs and treatments. The competition is directed at early-stage ventures aiming at developing new molecules for cancer treatment and is kindly supported by Cancer Research UK.

The competition is open to those seeking to further characterise or validate their drug target using cellular and molecular assays. We invite researchers around the world to join forces to find new drugs and bring them to market faster. Clinicians, postdoctoral researchers, established professors, virtual biotechs or even students - it is the quality of the idea that counts.

BioTarget also aims at raising awareness for entrepreneurship and innovation amongst scientists. It allows them to showcase their innovations to a greater audience and to meet leading biotech investors and industry professionals that can help them move their idea forward.

Following a first stage of the competition based on proposals submitted online, BioTarget now selects the 8 most promising projects, inviting them to a pitch event in London, UK.

During the pitch event, the finalists will present their projects, and a panel of experienced drug discovery researchers and investors will select the three winners, who will be awarded up to $100,000 in free experimentation conducted in Europe's leading cloud lab.

As part of London Tech Week, we are bringing BioTarget 2019 - the world’s first biotech competition for emerging companies dedicated to finding new molecules for cancer treatment - to Central Working White City.

The panelists/judges

Agenda:

18:00 Arrival and registration
18:30 Opening
18:35 CRUK Intro
18.40 Brief Fireside Chat with the Panel
19:00 Finalists' pitches
20:00 Drinks reception
20.45 Winner announcement

The finalists:

  • Macromoltek
  • NANOGAP Therapeutics
  • Delve Therapeutic
  • HOX Therapeutics
  • Synchrony
  • Arxeon
  • SpyCombinator - Highly combinatorial screen of multispecific ligands
  • CDK11B: New therapies from mischaracterized drugs

__________________________
About the organisers

About Cancer Research UK

Cancer Research UK is the world's largest independent cancer research charity that conducts research into the prevention, diagnosis and treatment of the disease. Research activities are carried out in institutes, universities and hospitals across the UK, both by the charity's own employees and by its grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness of the disease and influencing public policy. Cancer Research UK's work is almost entirely funded by the public. It raises money through donations, legacies, community fundraising, events, retail and corporate partnerships. Over 40,000 people are regular volunteers.

Official Website: https://www.cancerresearchuk.org/

About Arctoris

Based in Oxford, UK, Arctoris is the world's first fully automated cloud lab for cancer research, enabling academic scientists worldwide to directly configure a wide range of cancer research experiments online, and have them completed at its robotic facility. Arctoris offers its clients and partners a wide range of techniques to cover cellular and molecular biology, providing a platform solution from experiment design via robotic experimentation to data storage and visualisation.

Arctoris is actively partnering with academic centres and drug discovery companies to move their drug candidates forward, leveraging its robotic platform to generate data of unprecedented quality and depth.

Official Website: https://arctoris.com/

About Insilico Medicine, Inc

Insilico Medicine is an artificial intelligence company headquartered in Rockville, with R&D and management resources in Belgium, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.

Official Website: https://insilico.com/

Event Details

Free

London

December 9, 2019

December 9, 2019

Members only

Book a Ticket
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
OUR Events

These events aim to enhance the quality of Life of Seniors

All Events

Sep 18

Senior Care

Post-Summer Investor-Founder Mixer

To mourn the end of summer, we're bringing together both our BioFounder Club and BioCapital Network communities for an Investor-Founder Mixer.

London, UK

Apr 25

Senior Care

Biomaterials investor-founder dinner

From design of synthetic peptides to carbon-sequestering concrete, to sustainable fashion biomaterials are booming in today's market. Our mixer dinners offer unique opportunities for start-ups and investors alike.

Our latest updates. In your inbox. Once a month.

Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.